Icahn School of Medicine at Mount Sinai


University / College

Location:
New York, United States (USA)


Publications in cooperation with FAU scientists


Go to first page Go to previous page 2 of 3 Go to next page Go to last page
Kelemen, L.E., Earp, M., Fridley, B.L., Chenevix-Trench, G., Fasching, P., Beckmann, M.,... Berchuck, A. (2018). rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences, 19(9). https://dx.doi.org/10.3390/ijms19092473
Aziz, M.D., Shah, J., Kapoor, U., Dimopoulos, C.N., Ayuk, F.A., Hogan, W.J.,... Ferrara, J.L.M. (2018). Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Pavel, M.E., Gross, D.J., Benavent, M., Perros, P., Srirajaskanthan, R., Warner, R.R.P.,... Garcia-Carbonero, R. (2018). Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial. Endocrine-Related Cancer, 25(3), 309-322. https://dx.doi.org/10.1530/ERC-17-0455
Dillon, J., Dillon, J., Kulke, M., Warner, R., Bergsland, E., Welin, S.,... Pavel, M.E. (2018). Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Two Phase 3 Studies in Carcinoid Syndrome. (pp. 224-224).
Dillon, J.S., Kulke, M.H., Pavel, M.E., Horsch, D., Anthony, L.B., Warner, R.R.P.,... Lapuerta, P. (2018). Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study. (pp. 337-338).
Hirschfield, G., Boudes, P., Bowlus, C., Gitlin, N., Michael, G., Harrison, S.,... Jones, D. (2018). Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study. In JOURNAL OF HEPATOLOGY (pp. S105-S106). Paris, FR: AMSTERDAM: ELSEVIER SCIENCE BV.
Natanzon, Y., Kobel, M., Winham, S.J., Armasu, S.M., Mccauley, B.M., Vierkant, R.A.,... Goode, E.L. (2018). Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Panaccione, R., Atreya, R., Ferrante, M., Dubinsky, M.C., Sands, B.E., Abreu, M.T.,... Pangan, A.L. (2018). Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study. (pp. S412-S413).
Earp, M., Tyrer, J.P., Winham, S.J., Lin, H.-Y., Chornokur, G., Dennis, J.,... Phelan, C.M. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS ONE, 13(7). https://dx.doi.org/10.1371/journal.pone.0197561
Weickert, M.O., Kaltsas, G., Hoersch, D., Lapuerta, P., Pavel, M.E., Valle, J.W.,... Kulke, M.H. (2018). Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome. (pp. 357-358).
Goode, E.L., Block, M.S., Kalli, K.R., Vierkant, R.A., Chen, W., Fogarty, Z.C.,... Ramus, S.J. (2017). Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. JAMA Oncology, 3(12). https://dx.doi.org/10.1001/jamaoncol.2017.3290
Zega, K., Jovanovic, V.M., Vitic, Z., Niedzielska, M., Knaapi, L., Jukic, M.M.,... Brodski, C. (2017). Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool. Frontiers in Molecular Neuroscience, 10. https://dx.doi.org/10.3389/fnmol.2017.00372
Magadum, A., Ding, Y., He, L., Kim, T., Vasudevarao, M.D., Long, Q.,... Engel, F. (2017). Live cell screening platform identifies PPAR? as a regulator of cardiomyocyte proliferation and cardiac repair. Cell Research, 27(8), 1002-1019. https://dx.doi.org/10.1038/cr.2017.84
Sucheston-Campbell, L.E., Cannioto, R., Clay, A.I., Etter, J.L., Eng, K.H., Liu, S.,... Moysich, K.B. (2017). No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival. Cancer Epidemiology Biomarkers & Prevention, 26(3), 420-424. https://dx.doi.org/10.1158/1055-9965.EPI-16-0631
Agarwal, J., Kadakia, S., Agaimy, A., Ogadzanov, A., Khorsandi, A., & Chai, R.L. (2017). Pleomorphic liposarcoma of the head and neck: Presentation of two cases and literature review. American Journal of Otolaryngology, 38(4), 505-507. https://dx.doi.org/10.1016/j.amjoto.2017.04.012
Naoum, C., Berman, D.S., Ahmadi, A., Blanke, P., Gransar, H., Narula, J.,... Leipsic, J. (2017). Predictive Value of Age- and Sex-Specific Nomograms of Global Plaque Burden on Coronary Computed Tomography Angiography for Major Cardiac Events. Circulation-Cardiovascular Imaging, 10(3).
Jones, D., Boudes, P.F., Swain, M.G., Bowlus, C.L., Galambos, M.R., Bacon, B.R.,... Hirschfield, G.M. (2017). Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Lancet Gastroenterology and Hepatology, 2(10), 716-726. https://dx.doi.org/10.1016/S2468-1253(17)30246-7
Fahlbusch, R., Kleinberg, D., Biller, B., Bonert, V., Buchfelder, M., Cappabianca, P.,... Barkan, A. (2017). Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary, 20(6), 668-675. https://dx.doi.org/10.1007/s11102-017-0832-8
Tuncel, J., Haag, S., Hoffmann, M., Yau, A.C.Y., Hultqvist, M., Olofsson, P.,... Holmdahl, R. (2016). Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat. PLoS ONE, 11(5), e0155936. https://dx.doi.org/10.1371/journal.pone.0155936
Gaur, S., Ovrehus, K.A., Dey, D., Leipsic, J., Botker, H.E., Jensen, J.M.,... Norgaard, B.L. (2016). Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. European Heart Journal, 37(15), 1220-7. https://dx.doi.org/10.1093/eurheartj/ehv690

Last updated on 2016-14-10 at 15:19